Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christina Aquilante

Concepts (356)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
172
6.080
 Why?
Pharmacogenomic Testing
16
2026
62
4.430
 Why?
Thiazolidinediones
8
2016
139
2.550
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
45
2.230
 Why?
Heart Transplantation
9
2024
673
2.110
 Why?
Polymorphism, Genetic
17
2019
612
2.050
 Why?
Organ Transplantation
3
2024
247
1.660
 Why?
Cytochrome P-450 CYP3A
8
2024
93
1.550
 Why?
Precision Medicine
11
2025
453
1.490
 Why?
Genotype
20
2025
1843
1.440
 Why?
Polymorphism, Single Nucleotide
11
2024
2134
1.390
 Why?
Tacrolimus
3
2024
191
1.390
 Why?
Cytochrome P-450 CYP2C19
6
2024
26
1.290
 Why?
Health Personnel
4
2021
744
1.220
 Why?
Transplant Recipients
6
2024
180
1.180
 Why?
Hypoglycemic Agents
11
2020
1388
1.160
 Why?
Decision Support Systems, Clinical
2
2024
267
1.080
 Why?
Graft Rejection
3
2024
511
1.070
 Why?
Blood Pressure
8
2020
1763
1.050
 Why?
Metabolic Syndrome
4
2016
354
0.990
 Why?
Cytochrome P-450 CYP2D6
4
2022
32
0.960
 Why?
Immunosuppressive Agents
6
2024
834
0.870
 Why?
Pharmacists
3
2022
240
0.870
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
438
0.770
 Why?
Cost-Benefit Analysis
3
2024
637
0.730
 Why?
Gemfibrozil
2
2013
9
0.720
 Why?
Sulfonylurea Compounds
3
2018
51
0.690
 Why?
Adiponectin
2
2016
240
0.680
 Why?
Leukopenia
1
2021
33
0.680
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
21
0.680
 Why?
Dihydrouracil Dehydrogenase (NADP)
3
2026
4
0.670
 Why?
Hypolipidemic Agents
2
2013
89
0.670
 Why?
Warfarin
4
2024
171
0.660
 Why?
Mycophenolic Acid
1
2021
120
0.650
 Why?
Desogestrel
5
2021
45
0.640
 Why?
Organic Anion Transporters
2
2011
13
0.640
 Why?
Biological Specimen Banks
2
2024
105
0.630
 Why?
Platelet Aggregation Inhibitors
1
2024
495
0.620
 Why?
Hypertension
3
2020
1259
0.610
 Why?
Humans
83
2026
144298
0.590
 Why?
Prescription Drugs
2
2020
109
0.580
 Why?
Cytochrome P-450 CYP2C8
7
2014
14
0.570
 Why?
Cardiologists
1
2018
47
0.560
 Why?
Adult
43
2024
40408
0.550
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.540
 Why?
Middle Aged
41
2024
35892
0.540
 Why?
HIV Protease Inhibitors
4
2016
69
0.520
 Why?
Physicians
3
2021
948
0.520
 Why?
Ritonavir
4
2012
75
0.510
 Why?
Academic Medical Centers
1
2020
545
0.490
 Why?
Antimetabolites, Antineoplastic
3
2026
105
0.490
 Why?
Male
48
2024
72263
0.470
 Why?
Female
52
2024
78137
0.470
 Why?
Polypharmacy
1
2017
94
0.470
 Why?
Heart Failure
4
2017
2323
0.470
 Why?
Fluorouracil
3
2026
234
0.470
 Why?
Lectins
1
2016
45
0.470
 Why?
Nonprescription Drugs
1
2016
67
0.460
 Why?
Antiviral Agents
1
2021
764
0.440
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.440
 Why?
Attitude of Health Personnel
2
2020
1178
0.430
 Why?
Cytochrome P-450 Enzyme System
2
2006
161
0.420
 Why?
Contraceptive Agents, Female
3
2020
80
0.420
 Why?
Medicare
1
2020
888
0.410
 Why?
Death, Sudden, Cardiac
3
2021
230
0.400
 Why?
Pediatrics
2
2021
1118
0.390
 Why?
Blood Pressure Determination
1
2014
143
0.390
 Why?
Chemokine CXCL5
3
2012
19
0.380
 Why?
Heptanoic Acids
1
2013
67
0.380
 Why?
Arrhythmias, Cardiac
3
2021
355
0.380
 Why?
Pharmaceutical Preparations
3
2009
170
0.360
 Why?
Pyrazines
1
2013
92
0.360
 Why?
Resistin
2
2010
12
0.350
 Why?
Anticoagulants
3
2024
726
0.350
 Why?
Pravastatin
1
2011
44
0.350
 Why?
Pyrroles
1
2013
210
0.350
 Why?
Triazoles
1
2013
184
0.340
 Why?
Dobutamine
3
2008
24
0.340
 Why?
Diabetes Mellitus, Type 2
5
2020
2571
0.340
 Why?
Retrospective Studies
15
2024
17104
0.330
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1405
0.330
 Why?
Cross-Sectional Studies
8
2020
5862
0.320
 Why?
Managed Care Programs
2
2022
140
0.320
 Why?
Antidepressive Agents
2
2022
247
0.300
 Why?
Mixed Function Oxygenases
2
2008
49
0.300
 Why?
DNA
1
2016
1444
0.300
 Why?
Aged
19
2024
25901
0.300
 Why?
Drug Interactions
5
2017
401
0.290
 Why?
Chromatography, Liquid
1
2010
444
0.280
 Why?
Polymerase Chain Reaction
3
2006
1046
0.280
 Why?
Health
1
2008
80
0.270
 Why?
Cytokines
1
2016
2043
0.270
 Why?
Drug Prescriptions
4
2021
283
0.270
 Why?
International Normalized Ratio
2
2024
49
0.270
 Why?
Chemokine CCL2
1
2008
112
0.270
 Why?
Sulfonamides
1
2011
579
0.260
 Why?
Receptors, Adrenergic, beta
1
2008
58
0.260
 Why?
Mass Spectrometry
1
2010
741
0.260
 Why?
Drug Implants
4
2021
83
0.260
 Why?
Time Factors
8
2020
7128
0.260
 Why?
Electronic Health Records
4
2026
1174
0.260
 Why?
Young Adult
13
2021
14092
0.260
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.250
 Why?
Haplotypes
5
2013
490
0.250
 Why?
Heart Rate
3
2008
849
0.250
 Why?
Blood Glucose
3
2016
2326
0.250
 Why?
Sequence Analysis, DNA
4
2012
822
0.240
 Why?
United States
12
2025
15979
0.240
 Why?
Metoprolol
1
2006
26
0.240
 Why?
Vitamin K Epoxide Reductases
3
2020
11
0.240
 Why?
Clinical Laboratory Techniques
1
2006
96
0.230
 Why?
Autonomic Nervous System
1
2006
79
0.230
 Why?
Blood Coagulation Factors
1
2006
58
0.230
 Why?
Prospective Studies
7
2024
7972
0.230
 Why?
Models, Biological
1
2013
1807
0.220
 Why?
Clinical Protocols
2
2017
282
0.220
 Why?
Administration, Oral
4
2016
847
0.220
 Why?
Capecitabine
1
2025
57
0.220
 Why?
Genetic Variation
3
2019
982
0.220
 Why?
Echocardiography
1
2008
644
0.210
 Why?
Adrenergic beta-Antagonists
1
2006
250
0.210
 Why?
Echocardiography, Stress
1
2004
29
0.210
 Why?
Polymorphism, Restriction Fragment Length
1
2004
63
0.210
 Why?
Cross-Over Studies
3
2013
605
0.210
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
81
0.210
 Why?
Carrier Proteins
1
2008
733
0.200
 Why?
United States Food and Drug Administration
1
2024
204
0.200
 Why?
Follow-Up Studies
5
2024
5404
0.200
 Why?
Biotransformation
2
2013
63
0.200
 Why?
Cytochrome P-450 CYP2C9
4
2019
19
0.200
 Why?
Cohort Studies
7
2021
5948
0.190
 Why?
Metformin
1
2007
320
0.190
 Why?
Alleles
6
2012
881
0.190
 Why?
Waist Circumference
2
2016
141
0.190
 Why?
Gene Frequency
4
2013
480
0.180
 Why?
Dose-Response Relationship, Drug
4
2024
2012
0.180
 Why?
Antimalarials
2
2013
35
0.180
 Why?
Clinical Trials as Topic
1
2006
1055
0.170
 Why?
Drug Dosage Calculations
1
2020
27
0.160
 Why?
Calcineurin Inhibitors
1
2021
69
0.160
 Why?
Aged, 80 and over
5
2024
8265
0.160
 Why?
Pharmacogenomic Variants
2
2021
33
0.160
 Why?
Egypt
1
2020
13
0.160
 Why?
Antibiotics, Antineoplastic
1
2021
139
0.160
 Why?
Atazanavir Sulfate
3
2016
42
0.160
 Why?
Cytomegalovirus
1
2021
168
0.160
 Why?
Area Under Curve
2
2013
328
0.160
 Why?
No-Show Patients
1
2019
3
0.150
 Why?
Menstruation Disturbances
1
2019
13
0.150
 Why?
Diabetes Mellitus
2
2024
1075
0.150
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
68
0.150
 Why?
Smoking
1
2006
1466
0.150
 Why?
Brain Chemistry
1
2000
116
0.150
 Why?
Cytochrome P450 Family 3
1
2019
3
0.150
 Why?
Cardiovascular Diseases
3
2024
2170
0.150
 Why?
Colorado
3
2024
4554
0.150
 Why?
Hemodynamics
1
2004
1113
0.150
 Why?
Oligopeptides
2
2012
266
0.140
 Why?
Body Weight
2
2016
968
0.140
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
338
0.140
 Why?
Morphine
1
2000
169
0.140
 Why?
Patients
1
2020
181
0.140
 Why?
Child Health Services
1
2020
185
0.140
 Why?
Sitagliptin Phosphate
2
2021
31
0.140
 Why?
Progesterone
1
2019
209
0.140
 Why?
Double-Blind Method
2
2016
2032
0.140
 Why?
Lipids
2
2016
702
0.140
 Why?
Ventricular Dysfunction
1
2018
16
0.140
 Why?
Body Mass Index
3
2019
2417
0.130
 Why?
Psychiatry
1
2020
195
0.130
 Why?
Apyrase
1
2017
26
0.130
 Why?
Treatment Outcome
7
2024
11713
0.130
 Why?
Healthy Volunteers
2
2019
213
0.130
 Why?
Organophosphonates
2
2008
97
0.130
 Why?
Bariatric Surgery
1
2021
245
0.130
 Why?
DNA Primers
3
2006
507
0.120
 Why?
Pyrophosphatases
1
2016
25
0.120
 Why?
Pyridines
2
2012
601
0.120
 Why?
Chronic Disease
2
2017
1809
0.120
 Why?
Ribavirin
1
2016
80
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
268
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.120
 Why?
Students, Pharmacy
1
2016
95
0.110
 Why?
Patient Care
1
2016
118
0.110
 Why?
Cardiology
1
2018
359
0.110
 Why?
Anti-HIV Agents
2
2016
890
0.110
 Why?
Circadian Rhythm
1
2020
510
0.110
 Why?
Metabolic Clearance Rate
2
2013
115
0.110
 Why?
Depression
2
2022
1557
0.110
 Why?
Therapeutics
1
2015
14
0.110
 Why?
Adenine
2
2008
337
0.110
 Why?
Delivery of Health Care
1
2022
942
0.110
 Why?
Voriconazole
1
2015
21
0.110
 Why?
Education, Pharmacy
1
2016
119
0.110
 Why?
Surveys and Questionnaires
3
2026
6035
0.110
 Why?
beta-Cyclodextrins
1
2015
32
0.110
 Why?
HIV Infections
4
2016
3148
0.100
 Why?
Diltiazem
1
2014
17
0.100
 Why?
Patient Education as Topic
1
2019
771
0.100
 Why?
Surgical Procedures, Operative
1
2017
268
0.100
 Why?
Renal Replacement Therapy
1
2015
99
0.100
 Why?
Phenotype
3
2024
3139
0.100
 Why?
Antifungal Agents
1
2015
149
0.100
 Why?
Chromosomes, Human, Pair 10
1
2013
19
0.100
 Why?
Antigens, CD
1
2017
552
0.100
 Why?
Cardiomyopathies
1
2017
334
0.100
 Why?
Reoperation
1
2016
623
0.100
 Why?
Neoplasms
2
2026
2860
0.100
 Why?
Kidney Transplantation
1
2019
709
0.100
 Why?
Adolescent
6
2021
22370
0.100
 Why?
Half-Life
1
2013
152
0.090
 Why?
Medication Adherence
1
2017
540
0.090
 Why?
Venous Thromboembolism
1
2017
325
0.090
 Why?
Sirolimus
1
2014
280
0.090
 Why?
Liver Transplantation
1
2019
826
0.090
 Why?
Tissue Distribution
2
2014
333
0.090
 Why?
Darunavir
1
2011
20
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1359
0.090
 Why?
Self Care
1
2014
388
0.080
 Why?
Genetic Association Studies
1
2013
369
0.080
 Why?
Acquired Immunodeficiency Syndrome
1
2012
235
0.080
 Why?
Lung Transplantation
1
2014
329
0.080
 Why?
Reverse Transcriptase Inhibitors
2
2008
87
0.080
 Why?
Genetic Testing
2
2025
479
0.080
 Why?
Insulin Resistance
2
2010
1240
0.080
 Why?
Prevalence
1
2017
2836
0.080
 Why?
Cholesterol
1
2011
402
0.080
 Why?
Patient Discharge
1
2016
985
0.070
 Why?
Triglycerides
1
2011
517
0.070
 Why?
ATP-Binding Cassette Transporters
1
2010
118
0.070
 Why?
Leukocytes
2
2012
291
0.070
 Why?
Lipoproteins
1
2010
164
0.070
 Why?
Kidney Failure, Chronic
1
2015
596
0.070
 Why?
Longitudinal Studies
1
2016
2940
0.070
 Why?
Risk Assessment
3
2020
3680
0.070
 Why?
Lung Diseases
1
2014
780
0.060
 Why?
Incidence
2
2020
2886
0.060
 Why?
Databases, Factual
3
2021
1489
0.060
 Why?
Weight Gain
2
2021
557
0.060
 Why?
Indinavir
1
2006
7
0.060
 Why?
Linear Models
2
2019
845
0.060
 Why?
Pyrimidinones
1
2007
125
0.060
 Why?
Genetic Techniques
1
2006
67
0.060
 Why?
Drug Delivery Systems
1
2010
379
0.060
 Why?
Zidovudine
1
2006
77
0.060
 Why?
Lamivudine
1
2006
65
0.060
 Why?
Factor X
1
2006
25
0.060
 Why?
Prothrombin
1
2006
24
0.060
 Why?
Factor VII
1
2006
24
0.060
 Why?
Drug Utilization
1
2007
167
0.060
 Why?
Chemokines, CXC
1
2006
68
0.060
 Why?
Reproducibility of Results
1
2014
3408
0.060
 Why?
Base Sequence
2
2006
2171
0.060
 Why?
C-Reactive Protein
1
2008
420
0.060
 Why?
Oxidation-Reduction
1
2009
1073
0.060
 Why?
Regression Analysis
1
2008
997
0.060
 Why?
Biomarkers
3
2014
4248
0.060
 Why?
Prognosis
2
2014
4293
0.060
 Why?
Delayed-Action Preparations
1
2006
184
0.060
 Why?
Health Care Surveys
1
2007
537
0.060
 Why?
Pharmacovigilance
1
2024
23
0.050
 Why?
Gene Expression Regulation
1
2014
2589
0.050
 Why?
Mathematical Computing
1
2004
11
0.050
 Why?
Gene Expression
1
2009
1474
0.050
 Why?
Drug Labeling
1
2004
37
0.050
 Why?
Risk Factors
3
2020
10783
0.050
 Why?
Laboratories
1
2004
109
0.050
 Why?
Infusions, Intravenous
1
2004
422
0.050
 Why?
Algorithms
3
2024
1839
0.050
 Why?
Reference Values
1
2004
793
0.050
 Why?
Kidney
2
2008
1493
0.050
 Why?
Socioeconomic Factors
1
2007
1320
0.050
 Why?
Blood Coagulation
1
2024
265
0.050
 Why?
Linagliptin
1
2021
5
0.040
 Why?
Adamantane
1
2021
18
0.040
 Why?
Administrative Claims, Healthcare
1
2021
28
0.040
 Why?
Dipeptides
1
2021
56
0.040
 Why?
Electronic Prescribing
1
2021
3
0.040
 Why?
Uterine Hemorrhage
1
2021
41
0.040
 Why?
Electrocardiography
1
2004
663
0.040
 Why?
Drug Monitoring
1
2024
396
0.040
 Why?
Protective Factors
1
2020
99
0.040
 Why?
Drug Tolerance
1
2000
99
0.040
 Why?
Costs and Cost Analysis
1
2020
220
0.040
 Why?
Treatment Failure
1
2020
364
0.040
 Why?
Homozygote
2
2012
199
0.040
 Why?
Animals
3
2008
37800
0.040
 Why?
Kaplan-Meier Estimate
1
2021
966
0.040
 Why?
Sex Factors
1
2024
2103
0.040
 Why?
Genomics
1
2024
828
0.030
 Why?
Attitude
1
2020
260
0.030
 Why?
Glipizide
1
2018
6
0.030
 Why?
Glyburide
1
2018
31
0.030
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.030
 Why?
Antineoplastic Agents
1
2009
2194
0.030
 Why?
Proportional Hazards Models
1
2021
1322
0.030
 Why?
Dexamethasone
1
2000
366
0.030
 Why?
Social Class
1
2019
265
0.030
 Why?
Liver
1
2006
1884
0.030
 Why?
Feasibility Studies
1
2021
1098
0.030
 Why?
Self Report
1
2021
867
0.030
 Why?
Membrane Transport Proteins
2
2008
153
0.030
 Why?
Self-Management
1
2019
199
0.030
 Why?
Pharmaceutical Services
1
2016
76
0.030
 Why?
Peru
1
2016
62
0.030
 Why?
Anesthetics
1
2017
99
0.030
 Why?
Indians, North American
1
2021
597
0.030
 Why?
Diabetic Angiopathies
1
2018
262
0.030
 Why?
Medicaid
1
2020
464
0.030
 Why?
Tenofovir
2
2008
295
0.030
 Why?
Cause of Death
1
2018
463
0.030
 Why?
South Africa
1
2016
265
0.030
 Why?
Alternative Splicing
1
2017
245
0.030
 Why?
Perioperative Care
1
2017
231
0.030
 Why?
Hepatitis C, Chronic
1
2016
152
0.030
 Why?
Preoperative Care
1
2017
378
0.030
 Why?
HEK293 Cells
1
2017
741
0.030
 Why?
Receptors, Steroid
1
2014
41
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2512
0.030
 Why?
Everolimus
1
2014
111
0.020
 Why?
Demography
1
2014
287
0.020
 Why?
Hypoglycemia
1
2018
479
0.020
 Why?
Vasodilator Agents
1
2014
329
0.020
 Why?
Age Factors
1
2019
3324
0.020
 Why?
Heterozygote
1
2012
313
0.020
 Why?
Genetic Loci
1
2012
260
0.020
 Why?
Rats
1
2000
5553
0.020
 Why?
Mental Disorders
1
2020
1153
0.020
 Why?
Multivariate Analysis
1
2012
1537
0.020
 Why?
Insulin
1
2019
2500
0.020
 Why?
Body Composition
1
2012
689
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2348
0.020
 Why?
Critical Illness
1
2015
886
0.020
 Why?
Plasma
1
2009
220
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
15
0.010
 Why?
Ribosomal Proteins
1
2006
91
0.010
 Why?
Antiretroviral Therapy, Highly Active
1
2007
278
0.010
 Why?
Pharmacology
1
2005
11
0.010
 Why?
Molecular Sequence Data
1
2009
2896
0.010
 Why?
Likelihood Functions
1
2005
139
0.010
 Why?
Cardiotonic Agents
1
2005
94
0.010
 Why?
RNA, Messenger
1
2012
2808
0.010
 Why?
Mitochondrial Proteins
1
2006
262
0.010
 Why?
Chromosome Mapping
1
2005
506
0.010
 Why?
Genome
1
2006
305
0.010
 Why?
Drug Therapy, Combination
1
2006
1044
0.010
 Why?
Hemorrhage
1
2008
807
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
417
0.010
 Why?
Predictive Value of Tests
1
2008
2113
0.010
 Why?
Models, Genetic
1
2005
531
0.010
 Why?
Child
1
2020
22562
0.010
 Why?
Pilot Projects
1
2006
1880
0.010
 Why?
Computer Simulation
1
2005
1017
0.010
 Why?
Case-Control Studies
1
2007
3595
0.010
 Why?
Inflammation
1
2006
2862
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (356) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)